| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/26/2004 | US20040038378 Comprises isolated domain polypeptide of bacterial protein G which binds an Fab fragment of an immunoglobulin but not an Fc fragment; solid phase synthesis |
| 02/26/2004 | US20040038375 Method for screening highly active proteases and inhibitors |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038368 Improved pH stability; for washing and/or dishwashing detergents |
| 02/26/2004 | US20040038364 Such as snake venom proteases; anticoagulants |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038359 Gene 763 of phytopathogenic fungus magnaporthe grisea and use thereof for identifying fungicidal compounds |
| 02/26/2004 | US20040038358 Contains a ubiquitin pathway protein binding moiety which recognizes a ubiquitin pathway protein and a targeting moiety which recognizes a target protein |
| 02/26/2004 | US20040038349 Heteromultimeric TNF ligand family members |
| 02/26/2004 | US20040038348 Synthetic heparin-binding growth factor analogs |
| 02/26/2004 | US20040038347 Apoptosis inducing molecule I |
| 02/26/2004 | US20040038345 Discovery, identification and characterization of novel human polynucleotides that encode membrane associated proteins and receptors |
| 02/26/2004 | US20040038344 Compositions and methods of the invention provide isolated N-terminally truncated alpha6 integrin polypeptides, also called "alpha6 integrin variants," and methods of making the polypeptides |
| 02/26/2004 | US20040038343 Used in the diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections |
| 02/26/2004 | US20040038341 Chimeric human-type vascular endothelial cell growth factor |
| 02/26/2004 | US20040038340 Used in the processing of fermented foods by imparting an improved texture and flavor, and/or a higher content in aroma compounds; mutant has a mutation impairing the regulation of a carbon catabolite repression (CCR) mechanism |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038338 Influence of LRP cytoplasmic domain on Abeta production |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038333 Methods for protein refolding |
| 02/26/2004 | US20040038331 Solid phase synthesis of biomolecule conjugates |
| 02/26/2004 | US20040038325 Adhesion molecules |
| 02/26/2004 | US20040038322 Preventing metastasis and tumor expression via gene expression inhibition of kruppel like transcription factor; antisense therapy; antitumor agents; gene silencing agents |
| 02/26/2004 | US20040038312 Identifying modulators of g-protein coupled receptor associated with taste/flavor transduction; food processing and artificial sweetners |
| 02/26/2004 | US20040038299 Composition and method for modulating an inflammatory response |
| 02/26/2004 | US20040038298 Protein fragment complementation assays for the detection of biological or drug interactions |
| 02/26/2004 | US20040038297 Masp-2,a complement-fixing enzyme, and uses for it |
| 02/26/2004 | US20040038292 Comprises nucleotide sequences which code wound healing proteins for treatment and prevention of scarring, fibrosis, restenosis post angioplasty, psoriasis, benign prostatic hyperplasia, glaucoma and nervous suystem disorders |
| 02/26/2004 | US20040038291 Comprises immunoglobulin polypeptide library for diagnosis, prevention, suppression and/or treatment of inflammatory, cancer, viral, autoimmune and arthritic diseases |
| 02/26/2004 | US20040038285 Comprises polypeptide which possess hematopoietic, tissue generative/regeneration, activin/inhibin, chemotactic, hemostatic and thrombolytic activity for prevention and treatment autoimmune, viral and tumor disorders |
| 02/26/2004 | US20040038284 Using replication error phenotype (RER) to classify and prognose tumor disorders; immunoassay |
| 02/26/2004 | US20040038282 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038277 Comprises nucleotide sequences coding polypeptides containing signal sequences for diagnosis, prevention and treatment of reproductive, lung, blood, tumor, respiratory and autoimmune diseases |
| 02/26/2004 | US20040038276 Comprises nucleotide sequences coding cytokines for diagnosis, prevention and treatment of spinocerebellar ataxia, psychological and nervous system disorders |
| 02/26/2004 | US20040038275 Human frezzled-like protein |
| 02/26/2004 | US20040038274 Gapped 2' modified oligonucleotides |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/26/2004 | US20040038266 Diagnosing hereditary hearing loss in infants via presence or absence of mutation in connexin 26; microarray and high throughput assay |
| 02/26/2004 | US20040038265 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 02/26/2004 | US20040038252 Method of testing for allergic diseases |
| 02/26/2004 | US20040038249 Inducible expression systems employing PPAR transcriptional activators |
| 02/26/2004 | US20040038248 Novel polypeptide-human heterogeneous nuclear ribonucleoprotein 32.01 and the polynucleotide encoding said polypeptide |
| 02/26/2004 | US20040038243 P53-dependent apoptosis-associated protein and method of screening apoptosis controlling agent |
| 02/26/2004 | US20040038242 Novel secreted proteins and their uses |
| 02/26/2004 | US20040038239 A reporter system that transports GPI(glycosyl-phosphatidyl inositol-anchored proteins to the cell wall, was constructed and a gene that inhibit the transportaton of above protein is identified and a antifungal compound is discovered |
| 02/26/2004 | US20040038238 Comprises chimeric membrane proteins for diagnosis, treatment and prevention of inflammation, cancer, metabolic, gastrointestinal and autoimmune disorders |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038232 Compositions and methods for modulating tumor specific expression |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038226 Transgenic animal model by mineralocorticoid receptor antisense expression |
| 02/26/2004 | US20040038225 Diagnosing, detecting and classifying colon cancer via presence of colon marker polypeptides (COLOUP) |
| 02/26/2004 | US20040038224 Comprise polypeptide associated with diagnosis, prevention and treatment of familial cold urticaria, familial cold autoinflammatory syndrome and/or muckle wells syndrome |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038220 Methods for categorizing patients |
| 02/26/2004 | US20040038212 Novel armadillo repeat-containing protein alex1 |
| 02/26/2004 | US20040038210 Comprises nucleotide sequences coding extracellular protein for diagnosis, prevention and treatment of tumors, blood, viral and immunological diseases |
| 02/26/2004 | US20040038205 Modified adenoviral fiber and uses |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040038202 Comprises oligonucleotides for detection and treatment of gastrointestinal disorders in rodents; veterinary medicine |
| 02/26/2004 | US20040038196 Immunoblobulin directed against smallpox inhibitor of complement enzyme (SPICE) for preventing and treating poxviral infections |
| 02/26/2004 | US20040037852 Intramuscular or subcutaneous injection to treat a muscle disorder without development of an extensive local hypotonicity |
| 02/26/2004 | US20040037850 Incapable of expressing a functional g-protein due to a mutation in the gene encoding it |
| 02/26/2004 | US20040037848 Recombinant vaccine against West Nile Virus |
| 02/26/2004 | US20040037847 Assays for compounds that modulate rhadino virus lana action in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
| 02/26/2004 | US20040037846 Chlamydia pmp proteins, gene sequences and uses thereof |
| 02/26/2004 | US20040037843 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 02/26/2004 | US20040037842 Compositions and methods for the therapy and diagnosis of colon cancer |
| 02/26/2004 | US20040037839 T-cell receptor beta-like protein |
| 02/26/2004 | US20040037838 Polypeptide with the amino acid sequence of the C-terminal part of the circumsporozoite protein of a plasmodium in which cysteine residues are oxidized along with carriers, adjuvants and biodegradable microcapsules |
| 02/26/2004 | US20040037837 For stimulating CD8 T-cell response; tuberculosis vaccines; antigen presenting cells |
| 02/26/2004 | US20040037833 Comprises purified imunoglobulin polypeptide or antigen binding fragment for diagnosis of disease/cancer |
| 02/26/2004 | US20040037832 Transcription factor as repressor of expression of E-cadherin; detecting galactosidase activity; drug screening |
| 02/26/2004 | US20040037831 Pharmaceutical compositon comprising trkaig2 for use inthe prevention and/or treatment of cancer |
| 02/26/2004 | US20040037830 Assaying platelet factor 4 superfamily members (PF4A); interleukins; for medical diagnosis; antiinflammatory agents |
| 02/26/2004 | US20040037829 For immunoregulation and/or treatment of inflammation; muteins |
| 02/26/2004 | US20040037821 For expression of erythropoietin; genetic translocation; zinc finger motifs |
| 02/26/2004 | US20040037820 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 02/26/2004 | US20040037815 Isolation and use of solid tumor stem cells |
| 02/26/2004 | US20040037813 For production of organs for implantation; for inducing cell differentiation |
| 02/26/2004 | US20040037808 Methods for modulating T cell responses by manipulating a commom cytokine receptor gamma-chain |
| 02/26/2004 | US20040037805 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of |
| 02/26/2004 | US20040037802 Activated polymeric bicine derivatives such as polypeptides modified with these polymers exhibit reduced immunogenicity/antigenicity and circulate in the blood |
| 02/26/2004 | US20040037781 Peptides with antioxidant and antimicrobial properties |
| 02/26/2004 | US20040037775 Treating and preventing autoimmune diseases. The compositions and methods utilize peptides that are cell-specific. The peptides are conjugated to drugs. The peptide-drug conjugate can be internalized by the targeted cells thereby allowing for |
| 02/26/2004 | DE10237639A1 Preparing virus-like particles, useful as gene therapy vectors, comprises assembling capsomers, optionally with active molecules attached, in presence of nonionic stabilizers |
| 02/26/2004 | DE10233047A1 Preparing synthetic polypeptides, particularly fluorescent proteins, useful in pharmaceutical compositions, by aligning sequences of known proteins to define an average sequence |
| 02/26/2004 | DE10225139A1 Verfahren zur Identifizierung von immunreaktiven Peptiden A method for identifying immunoreactive peptides |
| 02/26/2004 | CA2535748A1 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | CA2497304A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | CA2496048A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 02/26/2004 | CA2495730A1 Avian sex determination method |
| 02/26/2004 | CA2495727A1 Nonhuman model animal nonresponsive to endotoxin and lipoprotein or lipopeptide |
| 02/26/2004 | CA2495680A1 Hepatitis c viral-like particle purification |
| 02/26/2004 | CA2495663A1 Compositions and methods for treating rage-associated disorders |
| 02/26/2004 | CA2495185A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | CA2494986A1 Method of plastid transformation in lettuce |